|Two start-ups supported by Biotechnology Industry Research Assistance Council have received the World Bank Group and the Consumer Technology Association’s Global Women’s Health Tech Awards. The start ups are NIRAMAI Health AnalytixPvt. Ltd. and InnAccel Technologies Pvt. Ltd. These awards recognise innovative startups that leverage technology to improve women’s health and safety in emerging markets. Department of Biotechnology’s Secretary Rajesh Gokhale said that as a funding agency, these success stories are a validation about the impact the department has created.
NIRAMAI Health AnalytixPvt. Ltd was selected for its novel software-based medical device that detects early-stage breast cancer in a simple and private way on women of all age groups and breast densities. The solution developed is a low cost, accurate, automated, portable, contactless, radiation-free, and painless cancer screening tool with no known side effects. Ministry of Science and Technology has said that over 45 thousand women have been screened so far through the startup’s tie-ups with over 30 hospitals and diagnostic centres across India. It said that the product can help 2 Billion women in the world to regularly screen for cancer. It added that the product can potentially save 90 thousand lives every year in India alone.
InnAccel Technologies Pvt Ltd. was adjudged a winner for Fetal Lite. It is a next-generation, AI-powered fetal heart rate monitor based on fetal ECG signal extraction technology for mothers in labour or post 37 weeks of gestation. Fetal Lite has next-gen ECG signal processing and is more accurate, reliable, and easier to use than the conventional Doppler-based devices while being comfortable for the mother. The device can be used for both active and remote monitoring in the in-hospital and in-home settings. Ministry of Science and Technology has said that the device has helped doctors to monitor 5 thousand cases including in tribal areas. It has the potential to save 1.2 million lives per year across the world.